Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 29, 2007
- Enrollment Completed for PIII of Prasugrel: Daiichi Sankyo
January 29, 2007
- TOPIC an article
January 29, 2007
- Molecular Imaging Research Symposium 2007
January 29, 2007
- Generic Companies, Med. Device Makers to Become Targets of M&A: Mr Yamaguchi of Nikko Citigroup
January 29, 2007
- Japan Should Participate in More Multinational Trials: Dr Sato of PMDA
January 29, 2007
- Study Group for Early Approval of Drugs to Focus on Microdosing Studies
January 29, 2007
- MPC, Tanabe Discuss Merger -Merger to Give Birth to 6th Largest Japanese Company-
January 29, 2007
- R&DNEWS IN BRIEF
January 29, 2007
- 58.2% Aware of DTC Disease Education Ads
January 29, 2007
- Novartis Begins Independent Sale of OTC Drugs
January 29, 2007
- Globalization Essential to Growth of Domestic Bioventures: Mr Yamazaki
January 29, 2007
- SELF-MEDICATION NEWS IN BRIEF
January 29, 2007
- Life Science to Account for 10-15% of Sales at Toyobo in 2010
January 29, 2007
- Nichi-Iko Aims at Sales of \43.0 Bil. in 2009
January 29, 2007
- BUSINESS NEWS IN BRIEF
January 29, 2007
- Sawai to Provide Add'l Data on Generics to Alleviate Doctors' Concerns
January 29, 2007
- Burgeoning Market for ARBs -Hot Battlefield for Megapharmas- Part 3
January 29, 2007
- Wholesalers Could Play Major Role in Popularizing GE Drugs: Report
January 29, 2007
- Prefectural Health Administration Officials' Meeting
January 29, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…